LifeTech Scientific logo

1302 - LifeTech Scientific Share Price

HK$2.05 -0.1  -4.2%

Last Trade - 9:08am

Mid Cap
Market Cap £886.9m
Enterprise Value £888.1m
Revenue £72.5m
Position in Universe 815th / 5992
Unlock 1302 Revenue
Relative Strength (%)
1m -16.5%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -27.6%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
282.7 311.6 352.8 409.1 556.7 668.9 733.8 879.9 +18.8%
+1,025 -26.0 +12.2 +20.3 +25.6
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, LifeTech Scientific Corp revenues decreased 12% to RMB273M. Net income increased 7% to RMB99M. Revenues reflect Structural heart disease business segment decrease of 36% to RMB79.3M. Net Income benefited from Peripheral Vascular Disease Business segment income increase of 2% to RMB153.9M. Basic Earnings per Share excluding Extraordinary Items remained flat at RMB0.02.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for 1302
Graphical History


1302 Revenue Unlock 1302 Revenue

Net Income

1302 Net Income Unlock 1302 Revenue

Normalised EPS

1302 Normalised EPS Unlock 1302 Revenue

PE Ratio Range

1302 PE Ratio Range Unlock 1302 Revenue

Dividend Yield Range

1302 Dividend Yield Range Unlock 1302 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
1302 EPS Forecasts Unlock 1302 Revenue
Profile Summary

LifeTech Scientific Corporation is an investment holding company principally engaged in the manufacturing and marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The Company operates through three business segments. The Congenital Heart Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to congenital and structural heart diseases. The Peripheral Vascular Diseases Business segment is engaged in the research and development, manufacture and trading of devices related to peripheral vascular diseases. The Surgical Vascular Repair Business segment is engaged in the research and development, manufacture and trading of devices related to surgical vascular repair.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated August 17, 2006
Public Since November 10, 2011
No. of Shareholders: n/a
No. of Employees: 778
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Hang Seng Composite , Hang Seng Composite Mid & SmallCap , Hang Seng Composite SmallCap ,
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 4,330,289,200
Free Float (0.0%)
Eligible for
1302 Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for 1302
Upcoming Events for 1302
Frequently Asked Questions for LifeTech Scientific
What is the LifeTech Scientific share price?

As of 9:08am, shares in LifeTech Scientific are trading at HK$2.05, giving the company a market capitalisation of £886.9m. This share price information is delayed by 15 minutes.

How has the LifeTech Scientific share price performed this year?

Shares in LifeTech Scientific are currently trading at HK$2.05 and the price has moved by 31.41% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the LifeTech Scientific price has moved by 30.59% over the past year.

What are the analyst and broker recommendations for LifeTech Scientific?

Of the analysts with advisory recommendations for LifeTech Scientific, there are there are currently 1 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for LifeTech Scientific is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will LifeTech Scientific next release its financial results?

LifeTech Scientific is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the LifeTech Scientific dividend yield?

LifeTech Scientific does not currently pay a dividend.

Does LifeTech Scientific pay a dividend?

LifeTech Scientific does not currently pay a dividend.

When does LifeTech Scientific next pay dividends?

LifeTech Scientific does not currently pay a dividend.

How do I buy LifeTech Scientific shares?

To buy shares in LifeTech Scientific you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of LifeTech Scientific?

Shares in LifeTech Scientific are currently trading at HK$2.05, giving the company a market capitalisation of £886.9m.

Where are LifeTech Scientific shares listed? Where are LifeTech Scientific shares listed?

Here are the trading details for LifeTech Scientific:

Country of listing: Hong Kong
Exchange: HKG
Ticker Symbol: 1302
What kind of share is LifeTech Scientific?

Based on an overall assessment of its quality, value and momentum, LifeTech Scientific is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a LifeTech Scientific share price forecast 2020?

Shares in LifeTech Scientific are currently priced at HK$2.05. At that level they are trading at 21.95% discount to the analyst consensus target price of 0.00.

Analysts covering LifeTech Scientific currently have a consensus Earnings Per Share (EPS) forecast of 0.0375487097 for the next financial year.

How can I tell whether the LifeTech Scientific share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like LifeTech Scientific. Over the past six months, the relative strength of its shares against the market has been -12.75%. At the current price of HK$2.05, shares in LifeTech Scientific are trading at 11.93% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the LifeTech Scientific PE Ratio?

The LifeTech Scientific PE ratio based on its reported earnings over the past 12 months is 55.65. The shares are currently trading at HK$2.05.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of LifeTech Scientific?

LifeTech Scientific's management team is headed by:

Yuehui Xie - CHM
Hsien-Tse Liang - NID
Deyuan Zhang - CSO
Jianxiong Liu - CFO
Guowei Zhan - DSL
Mark Cibuzar - DSL
Sajeevan Manikkoth - DSL
Luming Zhou - NID
Feng Jiang - NED
Jiangbo Han - COO
Wansong Wang - NID
Feng Fu - NED
Who are the major shareholders of LifeTech Scientific?

Here are the top five shareholders of LifeTech Scientific based on the size of their shareholding:

Xie (Yuehui) Individual Investor
Percentage owned: 18.06% (781.9m shares)
Central Huijin Investment Ltd. Sovereign Wealth Fund
Percentage owned: 10.8% (467.6m shares)
Bank of Communications Co Ltd Bank and Trust
Percentage owned: 7% (303.0m shares)
Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 5.97% (258.5m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 1.6% (69.1m shares)
Similar to 1302
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.